Cancer Diagnosis Program (CDP)

Green background with circles radiating and fading from the right. White text on the left states, “funds specimen resources and research to characterize tumors.”

The Cancer Diagnosis Program (CDP) strives to improve the diagnosis and assessment of cancer by effectively moving new scientific knowledge into clinical practice. This national program stimulates, coordinates and funds resources and research for the development of innovative biomarkers, novel diagnostic technologies and appropriate human specimens in order to better characterize cancers and allow improved medical decision making and evaluation of response to treatment.

CDP Resources

Cancer Diagnosis Research
Biospecimens and Biobanks
Technology Development
Biobanking and Biospecimen Science Research

Cancer Diagnosis Program (CDP) Organization

About CDP
Learn more about the mission and priorities of CDP
Contact CDP
Reach CDP staff members

Selected Funding Opportunities

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01)
Announcement Number: PAR-25-325
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3)
Announcement Number: PAR-25-074
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Gr
Announcement Number: PAR-24-304